iShares China Large-Cap ETF

Key Updates

FXI declined 2.37% to $35.62 since the March 9 report, reversing the prior period's recovery and establishing new multi-month lows. The ETF has now fallen 6.96% YTD and 12.96% over six months, with particularly sharp losses of 7.99% in the past month. This selloff occurs despite institutional optimism around Chinese AI valuations and regulatory approvals for cross-border investment products, indicating persistent structural concerns are outweighing tactical positives. A critical Financial Times investigation revealed systematic shareholder dilution as the primary factor behind Chinese equities' chronic underperformance relative to GDP growth, fundamentally challenging the investment thesis for broad China exposure.

Current Trend

FXI remains in a confirmed downtrend across all timeframes, with accelerating momentum in recent weeks. The 7.99% monthly decline represents the sharpest correction in the current cycle, breaking below support levels established during the February-March consolidation. YTD performance of -6.96% significantly underperforms both developed and emerging market benchmarks, while the 12.96% six-month decline confirms sustained capital outflows. The current price of $35.62 represents a multi-month low, with no clear technical support visible until levels substantially below current trading ranges. Short-term momentum indicators show continued deterioration, with five-day performance of -1.70% suggesting selling pressure remains intact despite previous optimism around tariff relief and AI developments.

Investment Thesis

The investment thesis for FXI centers on China's position as the world's second-largest AI hub and leader in robotics and electric vehicles, offering exposure to technological advancement at valuations substantially below US peers. Chinese internet giants like Tencent and Alibaba are deploying AI infrastructure at significantly lower capital intensity than US counterparts while maintaining $224 billion in cash reserves through 2030. However, this thesis faces fundamental structural challenges revealed by historical dilution patterns that caused earnings per share to compound at single-digit rates despite 14% annual total earnings growth since 2002. The thesis requires investors to believe that historical dilution mechanisms have been permanently resolved and that current valuations adequately compensate for governance risks inherent in Chinese equity structures.

Thesis Status

The investment thesis is under significant pressure and requires material reassessment. While tactical developments remain constructive—including Pzena Investment Management's increased exposure to Chinese AI companies and regulatory approvals for cross-border products—the Financial Times investigation fundamentally undermines the core assumption that Chinese equity investors can capture economic growth. The revelation that "stealth dilution" through conversion of non-tradeable shares exceeded combined market capitalization from all traditional issuance methods demonstrates a structural impediment to shareholder value creation. Price action confirms this reassessment, with FXI falling 2.37% since the last report despite positive news flow on AI valuations and tariff relief. The thesis can only remain viable if investors accept that dilution mechanisms have permanently ceased and that current 25% discounts to 2025 peaks adequately compensate for governance risks.

Key Drivers

The dominant driver is the structural dilution revelation showing Chinese equity investors experienced massive wealth transfer through share conversion and internal creation, particularly during bull markets when management issued shares equivalent to 25% of total market cap. This historical pattern explains why China's 27-fold nominal GDP growth failed to translate into proportionate equity returns. Counterbalancing this structural concern, institutional investors like Pzena are increasing Chinese AI exposure based on capital efficiency advantages, with Chinese firms projected to spend $240 billion through 2030 versus $650 billion forecast US tech capex by 2026. Currency management actions remain relevant, with the PBOC reducing forward trading reserve requirements to zero to moderate yuan appreciation that reached three-year highs. Regulatory developments include MRF scheme approvals for Fidelity and JPMorgan, potentially facilitating capital outflows that could pressure domestic equities. Trade dynamics show estimated tariff reductions to 24% from 32% following Supreme Court rulings, though benefits have failed to materialize in price performance.

Technical Analysis

FXI has broken down through all meaningful support levels established during the February-March consolidation period, with current price of $35.62 representing fresh multi-month lows. The 7.99% monthly decline shows accelerating downward momentum, while the -1.70% five-day performance indicates no stabilization despite oversold conditions. The ETF is trading 6.96% below YTD starting levels and 12.96% below six-month highs, with no clear support visible until substantially lower price levels. Volume patterns suggest sustained distribution rather than capitulation selling, indicating further downside risk. The failure to hold gains from the March 9 report's 2.14% bounce confirms that rallies are being sold, establishing a pattern of lower highs and lower lows consistent with a mature downtrend. Resistance now exists at the $36.50-$37.00 zone where previous support failed, while momentum indicators show continued deterioration across all timeframes.

Bull Case

• Chinese AI companies offer superior capital efficiency—Tencent and Alibaba are spending significantly less on AI infrastructure while focusing on practical applications, with $224 billion cash reserves through 2030 versus projected $650 billion US tech capex by 2026, as highlighted by Pzena's $3.9 billion fund that outperformed 97% of peers over five years
• China's technology leadership in AI, robotics, and EVs is attracting increased equity inflows from Southeast Asia and Europe seeking alternatives to US assets, with Deutsche Bank's global CIO noting China is the second-largest global AI hub amid dollar weakness and MSCI Asia Pacific gaining 12% YTD while S&P 500 remains flat
• Reduced US tariff burden to 24% from 32% following Supreme Court rulings on reciprocal tariffs improves export competitiveness, with MSCI China Index gaining over 1% and Hong Kong-listed Chinese firms jumping 2.7% on positive sentiment around trade normalization
• Regulatory approvals for cross-border investment products from Fidelity International and JPMorgan Asset Management under the MRF scheme demonstrate continued market opening and international institutional confidence in Chinese market infrastructure
• Historical dilution mechanisms have largely subsided in recent years according to Financial Times analysis, suggesting that the structural impediment to shareholder value creation that plagued Chinese equities for decades may no longer be operative going forward

Bear Case

• Systematic shareholder dilution eroded Chinese equity returns despite 27-fold GDP growth over thirty years, with "stealth dilution" through non-tradeable share conversion exceeding combined market cap from all traditional issuance, causing earnings per share to compound at single-digit rates versus 14% total earnings growth since 2002—management issued shares equivalent to 25% of total market cap during the 2007 bull market alone
• Chinese tech stocks remain 25% below 2025 peaks amid intensifying competition concerns, with broader market sentiment remaining negative despite institutional positioning in AI names, indicating persistent structural headwinds beyond cyclical factors
• PBOC currency intervention to moderate yuan appreciation reflects concerns about export competitiveness and economic fragility, with authorities reducing forward trading reserve requirements to zero and setting daily reference rates significantly weaker than market estimates to slow the currency's ten-consecutive-session rally to three-year highs
• Cross-border investment approvals may facilitate capital outflows as Chinese regulators historically use outbound quotas to manage capital flows and FX expectations, potentially channeling domestic capital overseas during yuan appreciation pressure and creating additional selling pressure on domestic equities
• Persistent downtrend across all timeframes with 6.96% YTD decline, 7.99% monthly loss, and 12.96% six-month decline demonstrates sustained capital outflows despite positive news on tariff relief and AI developments, with failure to hold March 9 recovery gains confirming rallies are being sold and establishing pattern of lower highs and lower lows